Cite

HARVARD Citation

    Barbour, A. et al. (n.d.). Dosing Strategy for Itacitinib, a Selective JAK1 Inhibitor, for the Treatment of Ulcerative Colitis. American journal of gastroenterology. p. . [Online]. 
  
Back to record